Advances in lung cancer research announced at conference
August 7, 2009Dr. Glen Weiss of the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare this week announced two significant advances in treating lung cancer at an international cancer research conference.
Dr. Weiss, M.D., an Associate Investigator in TGen's Cancer and Cell Biology Division and Director of Thoracic Oncology at TGen Clinical Research Services at Scottsdale Healthcare, made both announcements at the 13th World Conference on Lung Cancer in San Francisco.
In one presentation, Dr. Weiss described research that eventually could help prevent lung cancer from spreading to the brain. In non-small cell lung cancer (NSCLC), brain metastasis is a devastating complication that occurs in as many as 1 in 4 patients. The ability to identify those at risk for developing brain metastasis may guide new therapies.
A team led by Dr. Weiss found several microRNAs, which are single-stranded RNA molecules that regulate how genes control cellular development - as well as several high-tech imaging characteristics - all associated with the spread of lung cancer to the brain.
The biological significance of these microRNAs are being explored, and more studies are warranted, according to the team, which was funded by the Ibis Foundation of Arizona, the TGen Foundation and the Scottsdale Healthcare Foundation.
"With additional validation, this work can lead to better techniques to predict, treat and ultimately prevent brain metastasis in patients with non-small cell lung cancer," Dr. Weiss said. "Identifying the highest-risk population for brain metastasis, so that informed therapeutic trials can be undertaken, could enable a paradigmatic shift in treating these patients."
The study team included researchers from: TGen; the Virginia G. Piper Cancer Center at Scottsdale Healthcare's Scottsdale Clinical Research Institute; Scottsdale Medical Imaging LTD; and the School of Computing, Informatics and Decision Systems Engineering at Arizona State University's Ira A. Fulton School of Engineering.
In another presentation, Dr. Weiss discussed the release this week by Threshold Pharmaceuticals Inc. and the Virginia G. Piper Cancer Center at Scottsdale Healthcare of results from two Phase I clinical trials for a drug called TH-302.
The two clinical trials are both evaluating the safety and effectiveness of TH-302, a drug activated in the absence of oxygen. Both clinical trials involve patients with advanced solid tumors. In one, they are treated with TH-302 in combination with other chemotherapy agents. In the other, they are treated only with TH-302, which is produced by Threshold Pharmaceuticals of Redwood City, Calif.
In the study of those treated only with TH-302, six of eight, or 75 percent, of patients with small cell lung cancer (SCLC) "achieved stable disease or better." In the study of those treated with TH-302 in combination with other chemotherapy agents, eight of 12, or 67 percent, of patients with NSCLC "achieved stable disease or better," according to a release by Threshold and Scottsdale Healthcare. More details about the trials are available at www.shc.org/content.asp?lnavid=39.
"TH-302 is a new, novel, small molecule that is activated when cells are under conditions that lack oxygen, which is a metabolic condition characteristic of cancer cells," Dr. Weiss said. "We are excited to continue investigations with TH-302 and about the potential benefit that it might confer to people living with lung cancer."
Source: The Translational Genomics Research Institute
-
Personalized medicine helps cancer patients survive
Apr 20, 2009 |
not rated yet |
0
-
2 new therapies show promise for cancer patients
Apr 15, 2008 |
not rated yet |
0
-
Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients
Nov 13, 2008 |
not rated yet |
0
-
New genetic techniques to combat lung cancer
Apr 25, 2008 |
not rated yet |
0
-
Study shows drug combination improves outcome for advanced non-small cell lung cancer
May 31, 2009 |
not rated yet |
0
-
Fast photon control brings quantum photonic technologies closer
1 minute ago |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Tenofovir, leading HIV medication, linked with risk of kidney damage
(Medical Xpress) -- Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over ...
Medicine & Health / Medications
1 hour ago |
not rated yet |
0
|
New tumor suppressor gene identified
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...
43 minutes ago |
4 / 5 (1) |
0
Packard Children's has smallest child yet to get pacemaker
Jaya Maharaj was 15 minutes old when she was sent to surgery at Lucile Packard Childrens Hospital and given a pacemaker that saved her life. The tiny girl born nine weeks early, weighing 3.5 pounds, ...
Medicine & Health / Cardiology
26 minutes ago |
not rated yet |
0
Social psychologist: Lust makes you smarter and evidence that seven deadly sins are good for you
(Medical Xpress) -- Good news for lovers on Valentine’s Day - the seven deadly sins, including Lust, are good for you. University of Melbourne social psychologist Dr Simon Laham uses modern research to make a compelling ...
Medicine & Health / Psychology & Psychiatry
2 hours ago |
4.5 / 5 (2) |
0
Don't ignore kids' snores
(Medical Xpress) -- Your ears arent playing tricks on you that is the sound of snoring you hear from the bedroom of your preschooler. Snoring is common in children, but in some cases it can be a symptom of a ...
1 hour ago |
5 / 5 (1) |
0
Transforming galaxies
(PhysOrg.com) -- Many of the Universe's galaxies are like our own, displaying beautiful spiral arms wrapping around a bright nucleus. Examples in this stunning image, taken with the Wide Field Camera 3 on ...
'Smart' microcapsules in a single step
(PhysOrg.com) -- A new, single-step method of fabricating microcapsules, which have potential commercial applications in industries including medicine, agriculture and diagnostics, has been developed by researchers ...
A continent ablaze in auroral and manmade light
The North American continent is literally set ablaze in a confluence of Auroral and Manmade light captured in spectacular new videos snapped by the astronauts serving aboard the International Space Station ...
Ethanol mandate not the best option
Many people are willing to pay a premium for ethanol, but not enough to justify the government mandate for the corn-based fuel, a Michigan State University economist argues.
Nanostructured electrodes for rechargeable sodium-Ion batteries
Highly efficient 3V cathodes for rechargeable sodium-ion batteries have been developed by users from Argonne National Laboratory's Materials Science, Chemical Sciences & Engineering, and X-ray Sciences Divisions, ...
Aug 07, 2009
Rank: not rated yet
cause and effect of Oxygen orbits!